FDA approves Sunharbo, factor XIa inhibitor for reducing stroke

Coverage, in order

1. 2d ago
   first FDA Drug Safety / Drugs feed indie

   FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk

   FDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack.

2. 1d ago
   FDA Drug Safety / Drugs feed indie

   FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk breast cancer

   On September 17, 2024, the FDA approved ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) with an aromatase inhibitor and ribociclib and letrozole co-pack (Kisqali Femara Co-Pack, Novartis Pharmaceuticals Corporation) for early high-risk breast cancer.

3. 1d ago
   
   Medical Dialogues India obscure

   FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk

   The U.S. Food and Drug Administration has approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke…

4. 1d ago
   
   Healio indie

   FDA approves Sunharbo, factor XIa inhibitor for reducing stroke

   The FDA has approved Sunharbo, the only approved factor XIa inhibitor intended to reduce the risk for stroke in adults who recently experienced a non-cardioembolic ischemic stroke or high-risk transient ischemic attack. With the approval, physicians now have a treatment option that can lower…

5. 1d ago
   Nature Reviews Drug Discovery indie study

   First factor XIa inhibitor nabs FDA approval for stroke prevention

   Nature Reviews Drug Discovery, Published online: 11 November 2026; doi:10.1038/d41573-026-00180-9 First factor XIa inhibitor nabs FDA approval for stroke prevention

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.